News
Pfizer (NYSE:PFE) develops and sells biopharmaceutical products, including vaccines, treatments for infectious diseases, ...
Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...
Pfizer Inc. (NYSE:PFE) will release earnings results for the second quarter before the opening bell on Tuesday, Aug. 5.
CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...
Pfizer (PFE) stock is rising after the company reported strong second-quarter earnings and lifted its full-year forecast ...
Pfizer (PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 revenue guidance of $61 billion to ...
Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...
(PFE) on Tuesday reported second-quarter net income of $2.91 billion. The New York-based company said it had profit of 51 cents per share.
For many investors, the main point of stock picking is to generate higher returns than the overall market. But in ...
BUCHAREST, ROMANIA - Media OutReach Newswire - 6 August 2025 - Pfizer Romania has been officially certified as one of the ...
TipRanks on MSN21h
Pfizer’s Xeljanz Study: A Closer Look at Safety in Juvenile ArthritisPfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is currently conducting a post-marketing surveillance study ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback